Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Qing Li Peptide.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 127 | 99.64% | Sep 24, 2026 |
| Tirzepatide | 44 | 99.58% | Jun 17, 2026 |
| GHK-Cu | 38 | 99.77% | Sep 15, 2026 |
| BPC-157 | 34 | 98.34% | Sep 9, 2026 |
| Tesamorelin | 24 | 97.17% | Aug 12, 2026 |
| Ipamorelin | 16 | 99.67% | May 27, 2026 |
| TB-500 | 13 | 92.88% | Sep 15, 2026 |
| Melanotan II | 7 | 99.7% | Mar 13, 2026 |
| CJC-1295 No DAC | 7 | 98.66% | Aug 12, 2026 |
| PT-141 | 7 | 99.69% | Sep 4, 2026 |
| CJC-1295 DAC | 6 | 98.94% | Oct 3, 2025 |
| Sermorelin | 6 | 99.49% | Sep 4, 2026 |
| CJC-1295 | 6 | 99.39% | May 13, 2026 |
| MOTS-c | 6 | 98.82% | Aug 4, 2026 |
| TB-500 Thymosin Beta-4 | 5 | 99.38% | Mar 2, 2026 |
| Cagrilintide | 4 | 99.23% | Mar 6, 2026 |
| Survodutide | 3 | 98.9% | Oct 3, 2025 |
| Semaglutide | 3 | 99.49% | Feb 20, 2026 |
| TB-500 Fragment 17-23 | 1 | 95.7% | May 27, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Retatrutide | n/a | 99.9% | Lab E | Sep 24, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Sep 23, 2026 | verify |
| GHK-Cu | n/a | 98.5% | Lab L | Sep 15, 2026 | verify |
| TB-500 | n/a | n/a | Lab L | Sep 15, 2026 | verify |
| Retatrutide | RT15-050526 | 99.9% | Lab E | Sep 15, 2026 | verify |
| BPC-157 | n/a | 99.7% | Lab E | Sep 9, 2026 | verify |
| Sermorelin | n/a | 98% | Lab E | Sep 4, 2026 | verify |
| PT-141 | n/a | 99.7% | Lab E | Sep 4, 2026 | verify |
| BPC-157 | NHS-26014/QL-261108 | 99.6% | Lab G | Aug 28, 2026 | verify |
| GHK-Cu | n/a | 99.7% | Lab G | Aug 25, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 13, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 13, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | Aug 12, 2026 | verify |
| CJC-1295 No DAC | n/a | 98.5% | Lab E | Aug 12, 2026 | verify |
| Tesamorelin | n/a | 99.6% | Lab G | Aug 9, 2026 | verify |
| Retatrutide | n/a | 99.8% | Lab G | Aug 9, 2026 | verify |
| GHK-Cu | n/a | 99.7% | Lab G | Aug 9, 2026 | verify |
| BPC-157 | n/a | 98.9% | Lab E | Aug 5, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 4, 2026 | verify |
| MOTS-c | n/a | 99.2% | Lab E | Aug 4, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 3, 2026 | verify |
| Tesamorelin | TSM101 | 98.6% | Lab E | Jul 23, 2026 | verify |
| MOTS-c | n/a | 98.4% | Lab E | Jul 17, 2026 | verify |
| Retatrutide | 900-10 | 99.9% | Lab E | Jul 1, 2026 | verify |
| Retatrutide | MARCH 6,2026 | 99.9% | Lab E | Jun 24, 2026 | verify |
Showing 25 most recent of 357. Search the full database on the CoA page.
Sell or represent Qing Li Peptide? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/qing-li-peptide/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/qing-li-peptide.svg" alt="Qing Li Peptide: lab tested, 357 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.